Table of Contents
Biomarkers are biological molecules which act as indicator of a particular disease state or pharmacological conditions. Advancement in post genomic technologies, increasing R&D spending and dynamic applications of biomarkers in medicine will drive the future market growth.
The market for Biomarkers is classified into five categories based on types, application areas, therapeutic segments, products and by end users, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biomarkers market.
The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2014 are detailed.
The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.
The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biomarkers market and future opportunities that can propel the market.
The report contains the most detailed and in-depth segmentation and analysis of the Global Biomarkers Market during the forecast period 2014 - 2020.
Please note: this report requires certain updates. We have all the information available but require 2 business days to complete the process and ensure it is as up-to-date as possible.
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
Global Non-alcoholic Steatohepatitis Biomarker Market: Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). ...
The global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021. Increasing diagnostic applications of biomarkers, increasing ...
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...